Your browser doesn't support javascript.
loading
Progress on the hepatotoxicity of lipid-lowering drugs and its prevention strategies / 药学实践杂志
Journal of Pharmaceutical Practice ; (6): 412-415,464, 2014.
Article en Zh | WPRIM | ID: wpr-790376
Biblioteca responsable: WPRO
ABSTRACT
Hepatotoxicity is one of the most common adverse reactions during anti -hyperlipidemia treatment .Mechanisms of anti-hyperlipidemia drug-induced hepatotoxicity are not clear yet , but most of the toxic reactions are dose-related hypersensitivity and could be released after drug withdrawal .It is accepted that clinical risk factors for the development of hepatotoxicity during anti -hyper-lipidemia treatment are high age and chronic illnesses .Treatment of anti-hyperlipidemia drug-induced hepatotoxicity has not been uni-fied and most of the treatments are non-specific and symptomatic .Researching hypotoxicity and hepatoprotection antihyperlipidemia drug, especially TCM and pharmaceutics will become a promising direction .
Palabras clave
Texto completo: 1 Base de datos: WPRIM Idioma: Zh Revista: Journal of Pharmaceutical Practice Año: 2014 Tipo del documento: Article
Texto completo: 1 Base de datos: WPRIM Idioma: Zh Revista: Journal of Pharmaceutical Practice Año: 2014 Tipo del documento: Article